Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Quattro74on Aug 21, 2020 11:32am

130 Views

Post# 31438521

RE:From Mushrooms to medicine !

Ok Hatdawg, I want the recipe of your sweet-hot mushroom soup, yum. :-)

hatdawg wrote: when I was younger, I remember how me, and my siblings went to find mushrooms every afternoon for our Mushroom soup during dinner! a sweet, hot, delicious soup made out of mushrooms! That was such a sweet memories of me and mushrooms. Little did I know, Mushrooms can also be a potential cure of illness and can save lives! that was unexpected! These little tiny cute plants can be useful for our health! better be researching more about this mushrooms to know more about what it can do! (from mushrooms to medicine real quick! what a surprise!)

(from mushrooms to medicine real quick! what a surprise!)

these are called psilocybin mushrooms used for the treatment of obsessive-compulsive disorder, PTSD, opioid addiction, alcoholism, eating disorders, depression and anxiety, it’s only a matter of time before big pharmaceutical companies begin to invest heavily, and incorporate psychedelics into their own drug pipelines.